Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
2003 3
2004 5
2005 2
2006 7
2007 6
2008 14
2009 9
2010 16
2011 14
2012 25
2013 23
2014 27
2015 38
2016 43
2017 33
2018 31
2019 39
2020 44
2021 37
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

370 results
Results by year
Filters applied: . Clear all
Page 1
Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Sehn LH, Herrera AF, Flowers CR, Kamdar MK, McMillan A, Hertzberg M, Assouline S, Kim TM, Kim WS, Ozcan M, Hirata J, Penuel E, Paulson JN, Cheng J, Ku G, Matasar MJ. Sehn LH, et al. Among authors: cheng j. J Clin Oncol. 2020 Jan 10;38(2):155-165. doi: 10.1200/JCO.19.00172. Epub 2019 Nov 6. J Clin Oncol. 2020. PMID: 31693429 Free PMC article. Clinical Trial.
Systematic genome editing of the genes on zebrafish Chromosome 1 by CRISPR/Cas9.
Sun Y, Zhang B, Luo L, Shi DL, Wang H, Cui Z, Huang H, Cao Y, Shu X, Zhang W, Zhou J, Li Y, Du J, Zhao Q, Chen J, Zhong H, Zhong TP, Li L, Xiong JW, Peng J, Xiao W, Zhang J, Yao J, Yin Z, Mo X, Peng G, Zhu J, Chen Y, Zhou Y, Liu D, Pan W, Zhang Y, Ruan H, Liu F, Zhu Z, Meng A; ZAKOC Consortium. Sun Y, et al. Genome Res. 2019 Dec 12;30(1):118-26. doi: 10.1101/gr.248559.119. Online ahead of print. Genome Res. 2019. PMID: 31831591 Free PMC article.
Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS).
Morschhauser F, Flinn IW, Advani R, Sehn LH, Diefenbach C, Kolibaba K, Press OW, Salles G, Tilly H, Chen AI, Assouline S, Cheson BD, Dreyling M, Hagenbeek A, Zinzani PL, Jones S, Cheng J, Lu D, Penuel E, Hirata J, Wenger M, Chu YW, Sharman J. Morschhauser F, et al. Among authors: cheng j. Lancet Haematol. 2019 May;6(5):e254-e265. doi: 10.1016/S2352-3026(19)30026-2. Epub 2019 Mar 29. Lancet Haematol. 2019. PMID: 30935953 Clinical Trial.
A tutorial on pilot studies: the what, why and how.
Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios LP, Robson R, Thabane M, Giangregorio L, Goldsmith CH. Thabane L, et al. Among authors: cheng j. BMC Med Res Methodol. 2010 Jan 6;10:1. doi: 10.1186/1471-2288-10-1. BMC Med Res Methodol. 2010. PMID: 20053272 Free PMC article.
Does osimertinib treatment discriminate young patients?
Ji C, Zhong C, Sun SY. Ji C, et al. J Thorac Dis. 2019 Sep;11(Suppl 15):S1852-S1854. doi: 10.21037/jtd.2019.08.118. J Thorac Dis. 2019. PMID: 31632767 Free PMC article. No abstract available.
Functional analysis of Cullin 3 E3 ligases in tumorigenesis.
Cheng J, Guo J, Wang Z, North BJ, Tao K, Dai X, Wei W. Cheng J, et al. Biochim Biophys Acta Rev Cancer. 2018 Jan;1869(1):11-28. doi: 10.1016/j.bbcan.2017.11.001. Epub 2017 Nov 8. Biochim Biophys Acta Rev Cancer. 2018. PMID: 29128526 Free PMC article. Review.
370 results